The Rest Of Asia Pacific Single Use Surgical Instruments Market was valued at $153.52 Million in 2025 and projected to reach to $218.76 Million by 2030, representing a compound annual growth rate of 7.3%. Rest Of Asia Pacific's single-use surgical instruments market is poised for accelerated growth through 2030, driven by expanding surgical volumes in developing healthcare systems and increasing capital investments in medical infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific's 7.3% CAGR significantly outpaces the global market growth of 5.7%, positioning it as a high-momentum region for single-use surgical instruments investment and expansion.
The market is projected to expand from USD 153.52 million in 2025 to USD 218.76 million by 2030, representing a 42.5% increase over five years, driven by surgical volume acceleration across emerging economies.
Rising healthcare infrastructure investments across Rest Of Asia Pacific countries are enabling increased surgical capacity, hospital modernization, and adoption of advanced single-use instrument technologies.
Growing awareness and regulatory emphasis on infection prevention and control measures are driving rapid adoption of single-use surgical instruments as hospitals prioritize patient safety and reduce cross-contamination risks.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ENDOSCOPIC INSTRUMENTS (Product Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.7% from 2025 to 2030 |
| Largest Segment | HOSPITALS & SPECIALTY CLINICS (Care Setting) |
| Market Size Base Year (Billions) | ~USD 5.91 (2025) |
| Revenue Forecast (Billions) | ~USD 7.8 (2030) |
| Segments Covered | Product Type, Type, Application, Care Setting |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| JOHNSON & JOHNSON SERVICES, INC. (ETHICON, INC.) | United States | ||
| MEDTRONIC | Ireland | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| BD | United States | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| SMITH+NEPHEW | United Kingdom | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| STRYKER | United States | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| STERIS | Ireland | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| PAUL HARTMANN AG | Germany | Public Company | Handheld Surgical Instrument (single-use),Electrosurgical Instrument (single-use),Endoscopic Instrument (single-use), |
| TATA SURGICAL | India | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
Johnson & Johnson Services, Inc., operating through its Ethicon subsidiary, is a United States-based medical device and surgical products company.
Medtronic is a publicly traded Irish-founded company established in 1949 with approximately 95,000 employees, operating as a global medical technology leader.
BD (Becton Dickinson) is a publicly traded United States company founded in 1897 with 72,000 employees, specializing in medical devices and diagnostic solutions.
Smith+Nephew is a publicly traded United Kingdom company founded in 1856 with 16,988 employees, specializing in medical devices and surgical products.
Stryker is a publicly traded United States company founded in 1941 with 56,000 employees, operating as a leading medical technology and surgical equipment manufacturer.
STERIS is a publicly traded company founded in Ireland in 1985, providing sterilization and contamination control solutions for healthcare and life sciences.
Paul Hartmann AG is a publicly traded German company founded in 1818 with 10,066 employees, manufacturing medical and hygiene products.
Tata Surgical is an India-based surgical products company.
Rest Of Asia Pacific's single-use surgical instruments market is estimated at USD 153.52 million in 2025 and is projected to reach USD 218.76 million by 2030.
Rest Of Asia Pacific's market is growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2030, outpacing the global average of 5.7%.
Rest Of Asia Pacific's growth is driven by rising surgical volumes, expanding healthcare infrastructure, increasing infection control awareness, regulatory emphasis on patient safety, and the transition from reusable to disposable instruments.
Rest Of Asia Pacific demonstrates strong growth momentum with a 7.3% CAGR, positioning it as a high-growth segment within the broader Asia Pacific region and contributing significantly to regional market expansion.
Rest Of Asia Pacific offers substantial opportunities for manufacturers due to expanding healthcare access, rising middle-class populations, regulatory support for single-use instruments, and increasing surgical procedure volumes across emerging economies.
The study involved significant efforts to estimate the current size of the single-use surgical instruments market. Extensive secondary research was conducted to gather information about this market. The next step was to validate these findings, assumptions, and estimates through primary research with industry experts throughout the value chain. Various methodologies were used to calculate the total market size, including top-down and bottom-up approaches. Following this, market segmentation and data triangulation procedures were employed to estimate the sizes of the different segments and subsegments within the market.
This research study extensively utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Business, Factiva, whitepapers, and company documents from public registries. The secondary research was conducted to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the single-use surgical instruments (SUSI) market. It aimed to gather crucial insights about the top players in the market, as well as to classify and segment the market according to industry trends, geographical areas, and key developments. Additionally, a database of the leading industry players was compiled using the data collected through secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Supply-side primary sources included industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, engineers, and other key executives from companies and organizations operating in the SUSI market. Demand-side primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from both corporate and government bodies.
Breakdown of Primary Interviews
Note 1: C-level executives include CEOs, COOs, and CTOs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the SUSI market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

When the market size was determined, the entire market was split into three segments. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth.
The market rankings of major players were determined using secondary data from both paid and unpaid sources. This analysis focused on their sales of SUSI. In some cases, due to data limitations, the revenue share was estimated after a detailed review of the product portfolios of large companies and their individual sales performance. Additionally, this information was verified at each stage through in-depth interviews with industry professionals.
Single-use surgical instruments are sterile medical tools designed for one-time use during procedures. Their primary purpose is to ensure safety and prevent cross-contamination. This category includes handheld instruments such as forceps, scissors, and scalpels, as well as electrosurgical instruments like cautery devices and bipolar forceps. Additionally, it encompasses endoscopic instruments, including single-use trocars and graspers, which are commonly used in minimally invasive surgeries.
Full forecast, segment splits, and company analysis for all Single Use Surgical Instruments Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report